Medical and Pharmaceutical Medical cannabis cuts daily opioid-use in chronic pain patients: study The study adds to a body of emerging research suggesting pot is effective in reducing opioid use Natalia Buendia CalvilloJanuary 31, 2022
Business Tilray ekes out Q2 profit despite 16% drop in pot sales For better or for worse, the firm's focus appears to be moving further away from cannabis sales Nick LabaJanuary 10, 2022
Business Tilray chosen as supplier of medical pot in Luxembourg CEO Irwin Simon says EU markets represent a $1-billion opportunity to his firm Nick LabaOctober 26, 2021
Business Tilray signs deal with Great North Distributors to boost Canadian presence Great North is now the exclusive representative for Tilray's products nationwide Natalia Buendia CalvilloOctober 20, 2021
Business Tilray hires ex-Bacardi GM as president The firm will look to tap Blair MacNeil's beverage alcohol expertise in its search for profits Nick LabaOctober 19, 2021
Business Tilray says it’s fighting ‘ankle biters’ for sales in Q1 call As his firm struggles to outshine his competition, CEO Irwin Simon says he'll win over more customers by educating them on his brands in... Nick LabaOctober 7, 2021
Business Tilray confirms shutdown of flagship Nanaimo facility The company says it will work with employees interested in transitioning to its Broken Coast facility in North Cowichan Nick LabaSeptember 17, 2021
News Hexo to buy 48North Cannabis for $50M Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market Jared GnamMay 17, 2021
Canada Aurora stock falls amid more large losses and cost cuts With a massive $164.7M Q3 loss and a second round of cuts, the Edmonton producer is illustrative of troubles in the Canadian cannabis industry Jared GnamMay 14, 2021
News Tilray 1.0 quietly discloses first-quarter US$341M loss In the final quarter before merging with Aphria, Tilray shows fiscal weakness Jared GnamMay 11, 2021